Suchergebnisse - "Li, Zhenyu"

PubPharm (318)

1

Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes

enthalten in: Experimental hematology | 2023

von Fu, C. | Hu, X. | Wang, S. | +6

2

Prevalence of frailty among elderly patients with hip fracture in China : protocol for a systematic review and meta-analysis

enthalten in: BMJ open | 2023

von Xia, J. | Li, Z. | Zhao, D. | +2

3

Genetic variants in the vitamin D pathway and their association with vitamin D metabolite levels : Detailed studies of an inner-city pediatric population suggest a modest but significant effect in early childhood

enthalten in: The Journal of steroid biochemistry and molecular biology | 2023

von Fu, L. | Wong, B. | Li, Z. | +6

4

Synthesis of novel 5-amido-2-carboxypyrazines as inhibitors of the type three secretion system of Salmonella enterica serovar Typhimurium

enthalten in: Chemical biology & drug design | 2023

von Li, Z. | Su, J. | Liu, Z. | +2

5

Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients : A multi-centre study

enthalten in: British journal of haematology | 2023

von Zhou, L. | Fu, W. | Wu, S. | +22

6

MTH1 protects platelet mitochondria from oxidative damage and regulates platelet function and thrombosis

enthalten in: Nature communications | 2023

von Ding, Y. | Gui, X. | Chu, X. | +13

7

Toward a stable and low-resource PLM-based medical diagnostic system via prompt tuning and MoE structure

enthalten in: Scientific reports | 2023

von Dong, B. | Wang, Z. | Li, Z. | +12

8

The STAT3 inhibitor stattic overcome bortezomib-resistance in multiple myeloma via decreasing PSMB6

enthalten in: Experimental cell research | 2023

von Yuan, C. | Yuan, M. | Li, W. | +11

9

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

enthalten in: Cytotherapy | 2023

von Ma, S. | Li, H. | Zhou, D. | +18

10

Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma : latest updates from 2022 ASH Annual Meeting

enthalten in: Journal of hematology & oncology | 2023

von Xia, J. | Li, Z. | Xu, K.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]